Melanoma advocates hope a new Pharmac proposal will take the pressure off patients.
Consultation's open on whether to expand access to two immunotherapy medicines for people with stage 3b and 4 melanoma from May.
Used pre-surgery, nivolumab and ipilimumab can lower the chance of cancers returning.
Medical Oncologist and Melanoma Specialist Dr Gareth Rivalland tells Ryan about the difference it will make.

Full Show Podcast: 25 February 2026
34:29

Ryan Bridge: Businesses should be scared to take our data
03:11

Donna Demaio: Australia Correspondent on the push to remove Andrew Mountbatten-Windsor from the line of succession
02:49